Exact Mass: 508.2883
Exact Mass Matches: 508.2883
Found 500 metabolites which its exact mass value is equals to given mass value 508.2883
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
LysoPG(18:2(9Z,12Z)/0:0)
LysoPG(18:2(9Z,12Z)/0:0) is a lysophosphatidylglycerol. It is a glycerophospholipid in which a phosphoglycerol moiety occupies a glycerol substitution site. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic. However, it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Lysophosphatidylglycerols can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. LysoPG(18:2(9Z,12Z)/0:0), in particular, consists of one chain of linoleic acid at the C-1 position.
5beta-acetoxy-4beta,11-diangeloyloxy-8,10-dihydroxy-2beta,3beta-epoxy-bisabol-7(14)-ene
1beta,2beta,3beta,4beta,5beta,7alpha-hexahydroxy-spirost-25(27)-en-6-one
methyl 15,16-dideoxy-6alpha,15alpha,17beta-trihydroxy-15,17-oxidospongian-16-carboxylate 6,15,17-triacetate
2beta-acetoxy-1beta,8-diangeloyloxy-3beta,4beta-epoxy-10,11-dihydroxybisabol-7(14)-ene|4beta-acetoxy-5beta,8-diangeloyloxy-10,11-dihydroxy-2beta,3beta-epoxy-bisabol-7(14)-ene
3beta-angeloyloxy-9beta-acetoxy-8beta-angeloyloxy-4alpha,5alpha-dihydroxy-1beta,10alpha-epoxygermacr-11-ene
Atrotosterone C
pregn-5-ene-3,14-beta-dihydroxy-7,20-dione 3-O-beta-glucopyranoside
(1R*,2R*,3E,7E,11R*,12S*)-16-O-(3-hydroxy-3-methylglutaryl)-18-O-acetyldolabella-3,7-dien-2,16,18-triol
(1R*,2R*,3E,7E,11R*,12S*)-2-O-acetyl-16-O-(3-hydroxy-3-methylglutaryl)-dolabella-3,7-dien-2,16,18-triol
(3S,5R,6S,9R)-megastigman-3,9-diol 3-O-alpha-L-arabinofuranosyl-(1?6)-b-D-glucopyranoside
(2S,3aS)-5-(1-hydroxy-3-(4-methoxyphenyl)propylidene)-2-(2-hydroxypropan-2-yl)-3a,7-bis(3-methylbut-2-en-1-yl)tetrahydrobenzofuran-4,6(2H,5H)-dione|Flemiphilippinone A
solanolactoside C|solanolide 6-O-beta-D-quinovopyranoside
1beta-acetoxy-2beta,8-diangloyloxy-10,11-dihydroxy-3,4-epoxybisabol-7(14)-ene
(3S,5R,6S,9S)-megastigmane-3,9-diol 3-O-beta-D-(6-O-beta-D-apiofuranosyl)glucopyranoside|oblongionoside C
14beta-hydroxy-15alpha-(beta-D-glucopyranosyloxy)-17betaH-pregn-4-ene-3,20-dione|stemmoside B
5beta-acetoxy-4beta,10-diangeloyloxy-8,11-dihydroxy-2beta,3beta-epoxy-bisabol-7(14)-ene
3beta-angeloyloxy-9beta-acetoxy-8beta-senecioyloxy-4alpha,5alpha-dihydroxy-1beta,10alpha-epoxygermacr-11-ene
cyclo(N8-(alpha,alpha-dimethylallyl)-L-Trp-6a-(alpha,alpha-dimethylallyl)-L-Trp)
Ajugamarin B3|ajugamarin B3 ((12S)-19-acetoxy-6alpha,12-dihydroxy-1beta-<(2S)-2-methylbutanoyloxy>-4,18-epoxyneo-clerod-13(14)-en-15,16-olide)|ajugamarin B3 [(12S)-19-acetoxy-6alpha,12-dihydroxy-1beta-((2S)-2-methylbutanoyloxy)-4,18-epoxyneo-clerod-13(14)-en-15,16-olide]
21-O-beta-D-Glucosyl-14,21-dihydroxy-14beta-pregn-4-ene-3,20-dione
Phe Thr Asn Lys
Phe Asn Thr Lys
Asn Thr Phe Lys
2,5-Piperazinedione, 3-[[1-(1,1-dimethyl-2-propen-1-yl)-1H-indol-3-yl]methyl]-6-[[2-(1,1-dimethyl-2-propen-1-yl)-1H-indol-3-yl]methyl]-, (3S,6S)_120157
C32H36N4O2_8a,16a-Bis(2-methyl-3-buten-2-yl)-5a,8,8a,13,13a,15a,16,16a-octahydroindolo[3,2:4,5]pyrrolo[1,2:4,5]pyrazino[1,2:1,5]pyrrolo[2,3-b]indole-7,15(5H,7aH)-dione
(2E,4E)-1-[(2R,6S,14S,22S,25R)-25-(3,3-dimethyloxiran-2-yl)-15-methyl-1,3,13,15-tetraazaheptacyclo[18.4.1.0²,⁶.0⁶,²².0⁷,¹².0¹⁴,²².0¹⁶,²¹]pentacosa-7,9,11,16(21),17,19-hexaen-3-yl]hexa-2,4-dien-1-one
Ala Lys Lys Tyr
Ala Lys Gln Tyr
Ala Lys Tyr Lys
Ala Lys Tyr Gln
Ala Gln Lys Tyr
Ala Gln Tyr Lys
Ala Tyr Lys Lys
Ala Tyr Lys Gln
Ala Tyr Gln Lys
Phe Phe Pro Val
Phe Phe Val Pro
Phe Ile Met Val
Phe Ile Val Met
Phe Lys Lys Ser
Phe Lys Asn Thr
Phe Lys Gln Ser
Phe Lys Ser Lys
Phe Lys Ser Gln
Phe Lys Thr Asn
Phe Leu Met Val
Phe Leu Val Met
Phe Met Ile Val
Phe Met Leu Val
Phe Met Val Ile
Phe Met Val Leu
Phe Asn Lys Thr
Phe Pro Phe Val
Phe Pro Val Phe
Phe Gln Lys Ser
Phe Gln Ser Lys
Phe Ser Lys Lys
Phe Ser Lys Gln
Phe Ser Gln Lys
Phe Thr Lys Asn
Phe Val Phe Pro
Phe Val Ile Met
Phe Val Leu Met
Phe Val Met Ile
Phe Val Met Leu
Phe Val Pro Phe
His Lys Pro Gln
His Lys Gln Pro
His Pro Lys Gln
His Pro Gln Lys
His Gln Lys Pro
His Gln Pro Lys
Ile Phe Met Val
Ile Phe Val Met
Ile Ile Thr Tyr
Ile Ile Tyr Thr
Ile Leu Thr Tyr
Ile Leu Tyr Thr
Ile Met Phe Val
Ile Met Val Phe
Ile Thr Ile Tyr
Ile Thr Leu Tyr
Ile Thr Tyr Ile
Ile Thr Tyr Leu
Ile Val Phe Met
Ile Val Met Phe
Ile Tyr Ile Thr
Ile Tyr Leu Thr
Ile Tyr Thr Ile
Ile Tyr Thr Leu
Lys Ala Lys Tyr
Lys Ala Gln Tyr
Lys Ala Tyr Lys
Lys Ala Tyr Gln
Lys Phe Lys Ser
Lys Phe Asn Thr
Lys Phe Gln Ser
Lys Phe Ser Lys
Lys Phe Ser Gln
Lys Phe Thr Asn
Lys His Pro Gln
Lys His Gln Pro
Lys Lys Ala Tyr
Lys Lys Phe Ser
Lys Lys Ser Phe
Lys Lys Tyr Ala
Lys Asn Phe Thr
Lys Asn Thr Phe
Lys Pro His Gln
Lys Pro Gln His
Lys Gln Ala Tyr
Lys Gln Phe Ser
Lys Gln His Pro
Lys Gln Pro His
Lys Gln Ser Phe
Lys Gln Tyr Ala
Lys Ser Phe Lys
Lys Ser Phe Gln
Lys Ser Lys Phe
Lys Ser Gln Phe
Lys Thr Phe Asn
Lys Thr Asn Phe
Lys Tyr Ala Lys
Lys Tyr Ala Gln
Lys Tyr Lys Ala
Lys Tyr Gln Ala
Leu Phe Met Val
Leu Phe Val Met
Leu Ile Thr Tyr
Leu Ile Tyr Thr
Leu Leu Thr Tyr
Leu Leu Tyr Thr
Leu Met Phe Val
Leu Met Val Phe
Leu Thr Ile Tyr
Leu Thr Leu Tyr
Leu Thr Tyr Ile
Leu Thr Tyr Leu
Leu Val Phe Met
Leu Val Met Phe
Leu Tyr Ile Thr
Leu Tyr Leu Thr
Leu Tyr Thr Ile
Leu Tyr Thr Leu
Met Phe Ile Val
Met Phe Leu Val
Met Phe Val Ile
Met Phe Val Leu
Met Ile Phe Val
Met Ile Val Phe
Met Leu Phe Val
Met Leu Val Phe
Met Val Phe Ile
Met Val Phe Leu
Met Val Ile Phe
Met Val Leu Phe
Asn Phe Lys Thr
Asn Phe Thr Lys
Asn Lys Phe Thr
Asn Lys Thr Phe
Asn Thr Lys Phe
Pro Phe Phe Val
Pro Phe Val Phe
Pro His Lys Gln
Pro His Gln Lys
Pro Lys His Gln
Pro Lys Gln His
Pro Gln His Lys
Pro Gln Lys His
Pro Val Phe Phe
Gln Ala Lys Tyr
Gln Ala Tyr Lys
Gln Phe Lys Ser
Gln Phe Ser Lys
Gln His Lys Pro
Gln His Pro Lys
Gln Lys Ala Tyr
Gln Lys Phe Ser
Gln Lys His Pro
Gln Lys Pro His
Gln Lys Ser Phe
Gln Lys Tyr Ala
Gln Pro His Lys
Gln Pro Lys His
Gln Ser Phe Lys
Gln Ser Lys Phe
Gln Tyr Ala Lys
Gln Tyr Lys Ala
Ser Phe Lys Lys
Ser Phe Lys Gln
Ser Phe Gln Lys
Ser Lys Phe Lys
Ser Lys Phe Gln
Ser Lys Lys Phe
Ser Lys Gln Phe
Ser Gln Phe Lys
Thr Ile Ile Tyr
Thr Ile Leu Tyr
Thr Ile Tyr Ile
Thr Ile Tyr Leu
Thr Leu Ile Tyr
Thr Leu Leu Tyr
Thr Leu Tyr Ile
Thr Leu Tyr Leu
Thr Tyr Ile Ile
Thr Tyr Ile Leu
Thr Tyr Leu Ile
Thr Tyr Leu Leu
Val Phe Phe Pro
Val Phe Ile Met
Val Phe Leu Met
Val Phe Met Ile
Val Phe Met Leu
Val Phe Pro Phe
Val Ile Phe Met
Val Ile Met Phe
Val Leu Phe Met
Val Leu Met Phe
Val Met Phe Ile
Val Met Phe Leu
Val Met Ile Phe
Val Met Leu Phe
Val Pro Phe Phe
Tyr Ala Lys Lys
Tyr Ile Ile Thr
Tyr Ile Leu Thr
Tyr Ile Thr Ile
Tyr Ile Thr Leu
Tyr Lys Ala Lys
Tyr Lys Lys Ala
Tyr Leu Ile Thr
Tyr Leu Leu Thr
Tyr Leu Thr Ile
Tyr Leu Thr Leu
Tyr Thr Ile Ile
Tyr Thr Ile Leu
Tyr Thr Leu Ile
Tyr Thr Leu Leu
(5Z,7E)-(1S,3R)-26,26,26,27,27,27-hexafluoro-9,10-seco-5,7,10(19)-cholestatriene-1,3-diol
26,26,26,27,27,27-hexafluoro-25-hydroxyvitamin D3 / 26,26,26,27,27,27-hexafluoro-25-hydroxycholecalciferol
glas#20
An ascarosyloxycarboxylic acid beta-D-glucopyranosyl ester resulting from the formal esterification of the carboxy group of ascr#20 with the anomeric hydroxy group of beta-D-glucopyranose. It is a metabolite of the nematode Caenorhabditis elegans.
ST 28:3;O8
26,26,26,27,27,27-hexafluoro-1alphaa-hydroxyvitamin D3
26,26,26,27,27,27-hexafluoro-25-hydroxyvitamin D3
(2-Butyl-5-nitro-3-benzofuranyl)[4-[3-(dibutylamino)propoxy]phenyl]methanone
3,9-bis(isodecyloxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane
Sodium 2,2-methylene-bis-(4,6-di-tert-butylphenyl)phosphate
1-O-{(11R)-11-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]dodecanoyl}-beta-D-glucopyranose
2-(1,1-Dimethyl-2-propenyl)cyclo[L-Trp-2-(1,1-dimethyl-2-propenyl)-L-Trp-]
(3S)-3alpha-[1-(1,1-Dimethyl-2-propenyl)-1H-indole-3-ylmethyl]-6alpha-[2-(1,1-dimethyl-2-propenyl)-1H-indole-3-ylmethyl]piperazine-2,5-dione
1-[[(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-Hexadecanoyl-2-(5-hydroxypentanoyl)-sn-phosphatidate(2-)
1-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(3-methylbut-1-ynyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-3-(2-methoxyphenyl)-1-methylurea
1-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(3-methylbut-1-ynyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-3-(2-methoxyphenyl)-1-methylurea
2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(1-oxo-2-pyridin-4-ylethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-[(1-oxo-2-pyridin-4-ylethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
2-[(1R,3R,4aR,9aS)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
2-[(1S,3S,4aR,9aS)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
3-(4-fluorophenyl)-1-[(2S)-1-hydroxypropan-2-yl]-1-[(2S,3S)-3-methoxy-2-methyl-4-[methyl-[[4-(2-pyridinyl)phenyl]methyl]amino]butyl]urea
1-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(3-methylbut-1-ynyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-3-(2-methoxyphenyl)-1-methylurea
1-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(3-methylbut-1-ynyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-3-(2-methoxyphenyl)-1-methylurea
1-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(3-methylbut-1-ynyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-3-(2-methoxyphenyl)-1-methylurea
1-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(3-methylbut-1-ynyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-3-(2-methoxyphenyl)-1-methylurea
2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(2-pyridin-4-ylacetyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(2-piperidin-1-ylethyl)acetamide
2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(2-pyridin-4-ylacetyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(2-piperidin-1-ylethyl)acetamide
2-[(1S,3S,4aS,9aR)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
2-[(1R,3S,4aR,9aS)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
3-(4-fluorophenyl)-1-[(2R)-1-hydroxypropan-2-yl]-1-[(2S,3R)-3-methoxy-2-methyl-4-[methyl-[[4-(2-pyridinyl)phenyl]methyl]amino]butyl]urea
N-[(2S,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-pyridinecarboxamide
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[1-oxo-2-(2-pyridinyl)ethyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-[(1-oxo-2-pyridin-4-ylethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(1-oxo-2-pyridin-4-ylethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
2-[(1S,3R,4aS,9aR)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
2-[(1S,3R,4aR,9aS)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
3-(4-fluorophenyl)-1-[(2R)-1-hydroxypropan-2-yl]-1-[(2R,3S)-3-methoxy-2-methyl-4-[methyl-[[4-(2-pyridinyl)phenyl]methyl]amino]butyl]urea
3-(4-fluorophenyl)-1-[(2R)-1-hydroxypropan-2-yl]-1-[(2S,3S)-3-methoxy-2-methyl-4-[methyl-[[4-(2-pyridinyl)phenyl]methyl]amino]butyl]urea
N-[(2S,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-pyridinecarboxamide
N-[(2R,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-pyridinecarboxamide
N-[(2R,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-pyridinecarboxamide
N-[(2R,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-pyridinecarboxamide
N-[(2S,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-pyridinecarboxamide
N-[(2S,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-pyridinecarboxamide
(2S,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[1-oxo-2-(2-pyridinyl)ethyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[1-oxo-2-(2-pyridinyl)ethyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[1-oxo-2-(2-pyridinyl)ethyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[1-oxo-2-(2-pyridinyl)ethyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[1-oxo-2-(2-pyridinyl)ethyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[1-oxo-2-(2-pyridinyl)ethyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[1-oxo-2-(2-pyridinyl)ethyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(1-oxo-2-pyridin-4-ylethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(1-oxo-2-pyridin-4-ylethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
2-[(1R,3R,4aS,9aR)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
2-[(1R,3S,4aS,9aR)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
3-(4-fluorophenyl)-1-[(2S)-1-hydroxypropan-2-yl]-1-[(2S,3R)-3-methoxy-2-methyl-4-[methyl-[[4-(2-pyridinyl)phenyl]methyl]amino]butyl]urea
3-(4-fluorophenyl)-1-[(2S)-1-hydroxypropan-2-yl]-1-[(2R,3R)-3-methoxy-2-methyl-4-[methyl-[[4-(2-pyridinyl)phenyl]methyl]amino]butyl]urea
3-(4-fluorophenyl)-1-[(2S)-1-hydroxypropan-2-yl]-1-[(2R,3S)-3-methoxy-2-methyl-4-[methyl-[[4-(2-pyridinyl)phenyl]methyl]amino]butyl]urea
3-(4-fluorophenyl)-1-[(2R)-1-hydroxypropan-2-yl]-1-[(2R,3R)-3-methoxy-2-methyl-4-[methyl-[[4-(2-pyridinyl)phenyl]methyl]amino]butyl]urea
[3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (9Z,12Z)-octadeca-9,12-dienoate
2-[hydroxy-[3-propanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[3-acetyloxy-2-[(Z)-tetradec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
1-(9Z,12Z-octadecadienoyl)-glycero-3-phospho-(1-sn-glycerol)
MCP110
MCP110 is an inhibitor of Ras/Raf-1 interaction. MCP110 blocks the interaction of Ras with Raf. MCP110 disrupts this interaction might can be used for the research of human tumors[1].